ArticleJournal of vascular surgery cases and innovative techniques2025
A 3D-printed model of axillary cavernous hemangioma.
Article in Journal of vascular surgery cases and innovative techniques, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cavernous hemangioma is a benign hamartomatous proliferation of endothelial tissues that is found most frequently in the central nervous system. Extremity involvement is uncommon, and axillary involvement is particularly rare. We present the case of a 43-year-old man with a 2-year history of enlarging axillary mass. Magnetic resonance imaging demonstrated a peripherally enhancing lesion medial to the brachial vein and close to the medial brachial cutaneous nerve. A 3D-printed model was created based on magnetic resonance imaging, which elucidated the spatial relationship between the mass and surrounding structures. The mass was resected and pathology revealed a cavernous hemangioma. Here we discuss the utility of 3D modeling of a rare tumor.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.